Articles tagged "Cognitive dysfunction"

2017 International Congress
Using eye tracking to identify pupil and saccade biomarkers of neurodegenerative disease
D. Munoz, B. Coe, J. Huang, M. Smorenburg, D. Brien, S. Black, M. Borrie, D. Dowlatshahi, E. Finger, D. Grimes, M. Freedman, A. Lang, C. Marras, M. Masellis, R. Swartz, C. Tartaglia, L. Zinman, t. ONDRI Investigators (Kingston, ON, Canada)
Objective: The Ontario Neurodegeneration Research Initiative Program (1) is investigating patients with neurodegeneration (Alzheimer’s disease: AD; mild cognitive impairment: MCI; Parkinson’s disease: PD; amyotrophic lateral…
2017 International Congress
Self-awareness of cognitive functions in Parkinson’s disease patients with and without mild cognitive impairment.
M. Hoock, F. Maier, R. Kaur, C. Eggers, L. Timmermann (Cologne, Germany)
Objective: To examine whether Parkinson’s disease (PD) patients with or without mild cognitive impairment (MCI) show impaired self-awareness (ISA) of their cognitive abilities. Background: PD…
2017 International Congress
Subjective cognitive decline reflects recent cognitive change in non-demented patients with Parkinson’s disease
J.Y. Hong, Y. Lee, M. Sunwoo, Y. Sohn, P.H. Lee (Wonju, Republic of Korea)
Objective: We investigated whether subjective cognitive decline (SCD) can reflect recent cognitive change in patients with Parkinson’s disease (PD) who had shown non-demented cognitive performance…
2017 International Congress
The Effect of Anxiety on Cognition in Parkinson’s Disease
S. Anderson, G. Stebbins, B. Bernard, A. Negron, J. Goldman (Chicago, IL, USA)
Objective: Our study examined the effect of anxiety on cognition in Parkinson’s disease (PD) patients without cognitive impairment, mild cognitive impairment and dementia. Background: Anxiety…
2017 International Congress
Interactions between amyloid-β and microglial activation in Parkinson’s disease
C. Ghadery, Y. Koshimori, J. Kim, S. Coakeley, M. Harris, L. Christopher, P. Rusjan, A. Lang, S. Houle, A. Strafella (Toronto, ON, Canada)
Objective: To evaluate the relationship between microglial activation and amyloid-β deposition in the brain using positron emission tomography (PET) in Parkinson’s disease (PD) with normal…
2017 International Congress
U-shaped dopamine resting state connectivity response function related to working memory performance in adults with early-stage Parkinson’s disease
A. Metcalfe, S. Udow, H. Sharmarke, Z. Shirzadi, D. Long, S. Duff-Canning, C. Marras, A. Lang, B. MacIntosh, M. Masellis (Toronto, ON, Canada)
Objective: Appraise how cognitive performance and neural response is affected by nigrostriatal denervation in early-stage Parkinson’s disease (PD). Background: Cognitive dysfunction in PD is heterogeneous…
2017 International Congress
General Anesthesia and Parkinson’s Disease
C.-W. CHEN, K.-B. CHEN, Y.-C. KUO (TAICHUNG, Taiwan)
Objective: Postoperative cognitive dysfunction is common among the elderly. These changes may even be so severe that some elderly people actually become demented after undergoing…
2017 International Congress
A PSP-like phenotype accompanies rapidly progressive dementia
M. Dale, D. Erten-Lyons, F. Bittner, H.-Y. Jong, D. Bourdette, R. Woltjer (Charleston, SC, USA)
Objective: We describe a patient with a progressive supranuclear palsy (PSP)-like phenotype and a rapidly progressive dementia, who was found to have an unknown CSF…
2017 International Congress
Non-motor symptoms in ACDY5-associated disease
C. Amlang, M. Vidailhet, M. Amlang (Bronx, NY, USA)
Objective: To describe non-motor symptoms in a case of ACDY5-associated disease. Background: The hereditary dyskinesia syndrome caused by an ACDY5 mutation was first described in…
2017 International Congress
RBD predicts the cognitive impairment in Parkinson’s disease
E. Stefanova, T. Stojkovic, I. Stankovic, V. Kostic (Belgrade, Serbia)
Objective: To assess the relationship between the presence of Rapid eye movement sleep and behavior disorders RBD and the cognitive decline of non-demented patients with PD in…